2017 Research Updates
2017 Research
2017 Kenedy's Disease Conference Research Presentations
PSC/CRISPR Platform at the Montreal Neurological Institute - Lenore Beitel, PhD
Kennedy Disease and Pulmonary Considerations - Noah Lechtzin, MD, MHS
Kennedy Disease 101 - Ed Meyertholen, PhD
Maximizing Functional Independence - Kathy Farrell, MS, OTR/L
Metabolic Changes in SBMA - Dr. Andy Lieberman
Nutrition and Kennedy’s disease - Marnie Dobbin, MS, RDN & Angela Kokkinis, BSN, RN
PolyQLength-Specific Engineering of a HiPSCModel of SBMA Using CRISPR-Cas9 system - Xia Feng, PhD
Silencing of Mutant AR Co-activators as a Therapeutic Approach - Manuela Basso, PhD
Speech and Swallowing in KD: Soup to Nuts - Dr. Neil C. Porter
November 15, 2017 - MDA Announces SBMA Research Grant. For more information, please check out the Living with Kennedy's Disease blog. To view the blog, click here.
September 3, 2017 - New Treatment for SBMA approved in Japan. Check out the Living with Kennedy's Disease blog for comments on the study as well as a link to the original article which is written in Japanese. To view the blog, click here.
May 26, 2017 - The study, Identification of Neuron Selective Androgen Receptor Inhibitors was just published by the World Journal of Biological Chemistry this week. Check out the Living with Kennedy's Disease blog for comments on the study as well as links to the news article and published results. To view the blog, click here.
May 1, 2016 - Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy. To view the article, click here.
January 4, 2017 - The study, Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy was just published. Check out the Living with Kennedy's Disease blog for comments on the study as well as links to the news article and published results. To view the blog, click here.
January 13, 2017 - Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients. To view the article, click here.
January 24, 2017 - Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. To view the article, click here.
